Anal Incontinence and Its Impact on Quality of Life and Physical Activity Among Hungarian Women and the Hungarian Language Validation of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)
Prevalence of Anal Incontinence and Its Impact on Quality of Life and Physical Activity Among Hungarian Women Who Have Given Birth, and the Hungarian Language Validation of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Márta Hock, Phd
- Phone Number: +36-30-7213156
- Email: hock.marta@etk.pte.hu
Study Contact Backup
- Name: Eszter Ambrus
- Email: eszterkaja@gmail.com
Study Locations
-
-
Baranya
-
Pécs, Baranya, Hungary, H-7621
- Recruiting
- Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs
-
Contact:
- Márta Hock, Phd
- Phone Number: +36-30-7213156
- Email: hock.marta@etk.pte.hu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Have given birth at least once before
- Native Hungarian language
Exclusion Criteria:
- Menopause
- Irritable Bowel Syndrome (IBS)
- Chron's disease
- Ulcerative colitis
- Developmental abnormalities at the level of the pelvic organs
- Uninvestigated pelvic pain
- Malignant pelvic tumor
- Radiotherapy involving the pelvis
- Neurological diseases with muscle weakness
- Parkinson's disease
- Intellectual disability
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anal Incontinence Impact on Quality of Life
Time Frame: Through study completion, an average of 3 years
|
Assessing with questionnaire: International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B).
The ICIQ-B is a patient-completed questionnaire to assess the symptoms and impact on quality of life (QoL) of anal incontinence (including flatus incontinence).
The ICIQ-B consists of 21 items, divided into three domains: Bowel pattern (1 - 21), bowel control (0 - 28), Quality of life (0 - 26).
Seventeen items are scored items and the remaining four are unscored.
Higher scores indicate more symptoms.
|
Through study completion, an average of 3 years
|
|
Anal Incontinence Impact on Physical Activity
Time Frame: Through study completion, an average of 3 years
|
Assessing with questionnaire: Global Physical Activity Questionnaire (GPAQ).
The Global Physical Activity Questionnaire was developed by WHO to monitor physical activity in countries.
It collects information from 16 questions (P1-P16) on participation in physical activity in three domains (Workplace activity, Travel to and from places, Leisure activities) and sedentary behavior.
Metabolic equivalent (MET) values are applied to the time variables according to the intensity of the activity (moderate or high).
The application of MET values to activity levels allows the calculation of total physical activity.
|
Through study completion, an average of 3 years
|
|
Adaptation, validity and reliability of the Hungarian version of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)
Time Frame: Through study completion, an average of 3 years
|
Evaluating with statistical analysis the content/face validity, internal consistency, construct validity, test-retest reproducibility, discriminant validity and convergent validity.
|
Through study completion, an average of 3 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Additional pelvic floor symptoms
Time Frame: Through study completion, an average of 3 years
|
Assessing with questionnaire: The Hungarian version of the Australian Pelvic Floor Questionnaire (APFQ-H).
The APFQ-H consists of four domains: bladder function (15 items), bowel function (12 items), prolapse symptoms (5 items) and sexual function (10 items).
Thirty-eight of the items assess pelvic floor symptoms and four questions assess the bother caused by symptoms in each domain.
Most items in the questionnaire use a 4-point scoring system.
The score obtained for each domain ranges from 0 to 10.
The sum of the subscores in the four domains gives the APFQ-H global score.
The higher the score, the more severe the pelvic floor symptoms.
|
Through study completion, an average of 3 years
|
|
Global Quality of Life
Time Frame: Through study completion, an average of 3 years
|
Assessing with questionnaire: Hungarian WHOQOL-BREF.
The WHOQOL-BREF is a self-administered questionnaire that contains 26 questions about an individual's health and well-being over the previous two weeks.
Answers to the questions are given on a Likert scale of 1-5.
The WHOQOL-BREF covers four domains (physical health, psychological, social relationships, environment).
Scores in each of the 4 domains are converted into a scale ranging from 0 to 100.
A score of 0 represents the worst possible health status, while a score of 100 represents the best possible health status for that domain.
|
Through study completion, an average of 3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Márta Hock, PhD, University of Pécs Faculty of Health Sciences
- Principal Investigator: Eszter Ambrus, Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BM/5814-3/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.